The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
加拿大市场个股详情
INNO InnoCan Pharma Corp
- 0.185
- -0.010-5.13%
延时15分钟行情已收盘 12/20 10:38 (美东)
5308.36万总市值-15.42市盈率TTM
0.190最高价0.185最低价6000股成交量0.190今开0.195昨收1135.00成交额0.34052周最高0.00%换手率2.87亿总股本0.18052周最低-0.012每股收益TTM4100.84万流通值1.650历史最高亏损市盈率(静)2.22亿流通股0.050历史最低-0.023每股收益(静)2.56%振幅--股息TTM7.12市净率1股每手--股息率TTM
InnoCan Pharma Corp关键统计数据
季报+年报
显示同比
| (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 111.22%862.4万 | 176.96%864.4万 | 333.85%676.8万 | 433.69%1,365.7万 | 331.10%489.3万 | 445.13%408.3万 | 652.05%312.1万 | 500.00%156万 | 1,205.61%255.9万 | 6,993.75%113.5万 |
| 营业收入 | 111.22%862.4万 | 176.96%864.4万 | 333.85%676.8万 | 433.69%1,365.7万 | 331.10%489.3万 | 445.13%408.3万 | 652.05%312.1万 | 500.00%156万 | 1,205.61%255.9万 | 6,993.75%113.5万 |
| 主营业务成本 | 101.67%84.5万 | 38.92%64.6万 | 303.68%76.7万 | 271.46%167.9万 | 1,676.47%60.4万 | 1,132.35%41.9万 | 131.34%46.5万 | 4.40%19万 | 502.67%45.2万 | 466.67%3.4万 |
| 毛利 | 112.31%777.9万 | 201.13%799.8万 | 338.03%600.1万 | 468.49%1,197.8万 | 289.55%428.9万 | 412.45%366.4万 | 1,141.12%265.6万 | 1,656.41%137万 | 1,641.32%210.7万 | 10,910.00%110.1万 |
| 营业费用 | 52.51%742.7万 | 141.46%746.6万 | 173.63%721.3万 | 88.47%1,578.1万 | 106.49%518.3万 | 174.37%487万 | 41.12%309.2万 | 38.96%263.6万 | 10.16%837.3万 | 9.94%251万 |
| 销售和管理费用 | 58.82%705万 | 148.36%704.1万 | 234.10%678.9万 | 104.25%1,398.5万 | 117.32%467.9万 | 187.69%443.9万 | 63.78%283.5万 | 43.10%203.2万 | 10.40%684.7万 | 9.18%215.3万 |
| -销售费用 | 88.52%609.5万 | 168.20%595.4万 | 313.16%499.1万 | 265.54%1,046.9万 | 276.56%380.7万 | 350.91%323.3万 | 179.60%222万 | 253.22%120.8万 | 103.84%286.4万 | 101.80%101.1万 |
| -管理费用 | -20.81%95.5万 | 76.75%108.7万 | 118.20%179.8万 | -11.72%351.6万 | -23.64%87.2万 | 46.00%120.6万 | -34.36%61.5万 | -23.56%82.4万 | -16.97%398.3万 | -22.37%114.2万 |
| 研发费用 | -12.53%37.7万 | 65.37%42.5万 | -29.80%42.4万 | 17.69%179.6万 | 41.18%50.4万 | 85.78%43.1万 | -44.13%25.7万 | 26.62%60.4万 | 9.08%152.6万 | 14.79%35.7万 |
| 营业利润 | 129.19%35.2万 | 222.02%53.2万 | 4.27%-121.2万 | 39.31%-380.3万 | 36.55%-89.4万 | -13.77%-120.6万 | 77.95%-43.6万 | 30.40%-126.6万 | 16.23%-626.6万 | 38.01%-140.9万 |
| 营业外利息收入与支出净额 | 33.33%-2,000 | 50.00%3,000 | -155.56%-5,000 | 21.05%2.3万 | 150.00%1.5万 | -142.86%-3,000 | -81.82%2,000 | 280.00%9,000 | 246.15%1.9万 | 146.15%6,000 |
| 营业外利息收入 | --0 | 0.00%3,000 | --0 | 9.52%2.3万 | 62.50%1.3万 | --0 | -72.73%3,000 | --1万 | --2.1万 | --8,000 |
| 营业外利息支出 | -33.33%2,000 | ---- | 400.00%5,000 | --0 | -200.00%-2,000 | --3,000 | --1,000 | -80.00%1,000 | -84.62%2,000 | --2,000 |
| 其他净收入/费用 | 156.96%35.2万 | 2,265.79%89.9万 | -110.34%-3,000 | -110.77%-25.4万 | 26.92%29.7万 | -169.36%-61.8万 | -72.66%3.8万 | -97.35%2.9万 | 190.80%235.9万 | -86.08%23.4万 |
| 出售证券收益 | 156.96%35.2万 | 2,265.79%89.9万 | -110.34%-3,000 | -110.77%-25.4万 | 26.92%29.7万 | -169.36%-61.8万 | -72.66%3.8万 | -97.35%2.9万 | 190.80%235.9万 | -86.08%23.4万 |
| 税前利润 | 138.42%70.2万 | 462.12%143.4万 | 0.65%-122万 | -3.76%-403.4万 | 50.21%-58.2万 | -1,027.78%-182.7万 | 78.33%-39.6万 | -68.45%-122.8万 | 61.47%-388.8万 | -93.22%-116.9万 |
| 所得税 | 41.8万 | 47.8万 | 23.4万 | 21,300.00%21.4万 | 21,300.00%21.4万 | 0 | 0 | 0 | 1,000 | 1,000 |
| 除税后的权益收益 | ||||||||||
| 除税后利润 | 115.54%28.4万 | 341.41%95.6万 | -18.40%-145.4万 | -9.23%-424.8万 | 31.97%-79.6万 | -1,027.78%-182.7万 | 78.33%-39.6万 | -68.45%-122.8万 | 61.46%-388.9万 | -93.39%-117万 |
| 持续经营利润 | 115.54%28.4万 | 341.41%95.6万 | -18.40%-145.4万 | -9.23%-424.8万 | 31.97%-79.6万 | -1,027.78%-182.7万 | 78.33%-39.6万 | -68.45%-122.8万 | 61.46%-388.9万 | -93.39%-117万 |
| 归属于少数股东的净利润 | 187.00%57.4万 | 399.19%61.9万 | 645.24%31.3万 | 461.60%45.2万 | 135.14%8.7万 | 3,233.33%20万 | 236.26%12.4万 | 153.85%4.2万 | -184.09%-12.5万 | 212.12%3.7万 |
| 归属于母公司的净利润 | 85.69%-29万 | 164.81%33.7万 | -39.13%-176.7万 | -24.87%-470万 | 26.84%-88.3万 | -1,106.55%-202.7万 | 70.05%-52万 | -95.08%-127万 | 62.54%-376.4万 | -111.01%-120.7万 |
| 优先股派息 | ||||||||||
| 其他优先股派息 | ||||||||||
| 归属于普通股股东的净利润 | 85.69%-29万 | 164.81%33.7万 | -39.13%-176.7万 | -24.87%-470万 | 26.84%-88.3万 | -1,106.55%-202.7万 | 70.05%-52万 | -95.08%-127万 | 62.54%-376.4万 | -111.01%-120.7万 |
| 基本每股收益 | 85.71%-0.001 | 150.00%0.001 | 0.00%-0.005 | -6.25%-0.017 | 40.00%-0.003 | -600.00%-0.007 | 71.43%-0.002 | -66.67%-0.005 | 68.00%-0.016 | 16.67%-0.005 |
| 稀释每股收益 | 85.71%-0.001 | 150.00%0.001 | 0.00%-0.005 | -6.25%-0.017 | 40.00%-0.003 | -600.00%-0.007 | 71.43%-0.002 | -66.67%-0.005 | 68.00%-0.016 | 16.67%-0.005 |
| 每股派息 | ||||||||||
| 会计准则 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| 审计意见 | -- | -- | -- | 带解释段的无保留意见 | -- | -- | -- | -- | 带解释段的无保留意见 | -- |
FY：Financial Year 年度报告，相当于上市公司向SEC披露的10-K文件。
Q：Quarter 季度报告，相当于上市公司向SEC披露的10-Q文件，其中Q1、Q2、Q3、Q4为单季报，跨度为3个月；Q6、Q9为累计季报，Q6为6个月，Q9为9个月。